MXPA05012562A - Combinaciones antiartritis. - Google Patents
Combinaciones antiartritis.Info
- Publication number
- MXPA05012562A MXPA05012562A MXPA05012562A MXPA05012562A MXPA05012562A MX PA05012562 A MXPA05012562 A MX PA05012562A MX PA05012562 A MXPA05012562 A MX PA05012562A MX PA05012562 A MXPA05012562 A MX PA05012562A MX PA05012562 A MXPA05012562 A MX PA05012562A
- Authority
- MX
- Mexico
- Prior art keywords
- combinations
- antiarthritic
- arthritis
- erbeta
- inhibition
- Prior art date
Links
- 230000002456 anti-arthritic effect Effects 0.000 title 1
- 206010003246 arthritis Diseases 0.000 abstract 2
- 101100501785 Rattus norvegicus Esr2 gene Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/055—Phenols the aromatic ring being substituted by halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Esta invencion proporciona combinaciones de un ligando selectivo de ER( con un agente anti-artritis, que son utiles en el tratamiento o la inhibicion de la artritis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47238203P | 2003-05-21 | 2003-05-21 | |
PCT/US2004/016030 WO2004103365A1 (en) | 2003-05-21 | 2004-05-20 | Antiarthritic combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05012562A true MXPA05012562A (es) | 2006-04-18 |
Family
ID=33476949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05012562A MXPA05012562A (es) | 2003-05-21 | 2004-05-20 | Combinaciones antiartritis. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040248865A1 (es) |
EP (1) | EP1631283A1 (es) |
JP (1) | JP2007500223A (es) |
KR (1) | KR20060013666A (es) |
CN (1) | CN1791404A (es) |
AR (1) | AR044428A1 (es) |
AU (1) | AU2004240668A1 (es) |
BR (1) | BRPI0411145A (es) |
CA (1) | CA2524116A1 (es) |
CL (1) | CL2004001186A1 (es) |
EC (1) | ECSP056177A (es) |
MX (1) | MXPA05012562A (es) |
NO (1) | NO20056070L (es) |
RU (1) | RU2005140041A (es) |
TW (1) | TW200500065A (es) |
WO (1) | WO2004103365A1 (es) |
ZA (1) | ZA200509376B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006060542A2 (en) * | 2004-12-02 | 2006-06-08 | Wyeth | Formulations of substituted benzoxazoles |
US20060210644A1 (en) * | 2004-12-16 | 2006-09-21 | Bruce Levin | Materials, methods, and devices for treatment of arthropathies and spondylopathies |
KR20080002790A (ko) * | 2005-03-29 | 2008-01-04 | 코와 가부시키가이샤 | 관절 류머티즘의 예방 및/또는 치료약 |
JP2009526851A (ja) * | 2006-02-14 | 2009-07-23 | ワイス | ERβ選択的リガンドの水性薬学的配合物 |
RU2367430C1 (ru) * | 2008-04-16 | 2009-09-20 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Способ прогноза эффективности лечения ревматоидного артрита симвастатином |
ES2429592T3 (es) * | 2008-04-22 | 2013-11-15 | Toyama Chemical Co., Ltd. | Combinación de un derivado de benzofenona o de una sal del mismo y de un agente inmunosupresor y composición farmacéutica que contiene estos componentes |
JP6049455B2 (ja) * | 2009-05-18 | 2016-12-21 | ザ ユニバーシティ オブ ホンコンThe University of Hong Kong | 炎症性関節炎を治療するための組成物および方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
KR20010082184A (ko) * | 1998-08-28 | 2001-08-29 | 추후제출 | p38-α 키나제의 저해체 |
US6080580A (en) * | 1998-10-05 | 2000-06-27 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression |
US6225311B1 (en) * | 1999-01-27 | 2001-05-01 | American Cyanamid Company | Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
US6541477B2 (en) * | 1999-08-27 | 2003-04-01 | Scios, Inc. | Inhibitors of p38-a kinase |
JP2004515496A (ja) * | 2000-12-07 | 2004-05-27 | アストラゼネカ・アクチエボラーグ | ベンズイミダゾール治療剤 |
US6589980B2 (en) * | 2001-05-17 | 2003-07-08 | Wyeth | Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents |
UA83620C2 (ru) * | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
TWI306450B (en) * | 2001-12-13 | 2009-02-21 | Wyeth Corp | Substituted phenyl naphthalenes as estrogenic agents |
-
2004
- 2004-05-05 TW TW093112596A patent/TW200500065A/zh unknown
- 2004-05-20 RU RU2005140041/14A patent/RU2005140041A/ru not_active Application Discontinuation
- 2004-05-20 US US10/849,761 patent/US20040248865A1/en not_active Abandoned
- 2004-05-20 WO PCT/US2004/016030 patent/WO2004103365A1/en active Application Filing
- 2004-05-20 MX MXPA05012562A patent/MXPA05012562A/es unknown
- 2004-05-20 AU AU2004240668A patent/AU2004240668A1/en not_active Abandoned
- 2004-05-20 CN CNA200480013794XA patent/CN1791404A/zh active Pending
- 2004-05-20 CL CL200401186A patent/CL2004001186A1/es unknown
- 2004-05-20 JP JP2006533294A patent/JP2007500223A/ja active Pending
- 2004-05-20 BR BRPI0411145-1A patent/BRPI0411145A/pt not_active IP Right Cessation
- 2004-05-20 CA CA002524116A patent/CA2524116A1/en not_active Abandoned
- 2004-05-20 KR KR1020057021986A patent/KR20060013666A/ko not_active Withdrawn
- 2004-05-20 EP EP04752951A patent/EP1631283A1/en not_active Withdrawn
- 2004-05-21 AR ARP040101779A patent/AR044428A1/es unknown
-
2005
- 2005-11-18 ZA ZA200509376A patent/ZA200509376B/en unknown
- 2005-11-18 EC EC2005006177A patent/ECSP056177A/es unknown
- 2005-12-20 NO NO20056070A patent/NO20056070L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007500223A (ja) | 2007-01-11 |
EP1631283A1 (en) | 2006-03-08 |
BRPI0411145A (pt) | 2006-07-11 |
WO2004103365A1 (en) | 2004-12-02 |
CL2004001186A1 (es) | 2005-04-15 |
KR20060013666A (ko) | 2006-02-13 |
CA2524116A1 (en) | 2004-12-02 |
ZA200509376B (en) | 2007-04-25 |
CN1791404A (zh) | 2006-06-21 |
NO20056070L (no) | 2006-02-14 |
ECSP056177A (es) | 2006-04-19 |
AR044428A1 (es) | 2005-09-14 |
RU2005140041A (ru) | 2006-05-10 |
US20040248865A1 (en) | 2004-12-09 |
AU2004240668A1 (en) | 2004-12-02 |
TW200500065A (en) | 2005-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007059041A3 (en) | Combinations and methods of using an immunomodulatory oligodeoxynucleotide | |
TW200420573A (en) | Bifunctional heterocyclic compounds and methods of making and using same | |
GB0305175D0 (en) | Navigator 2.0 features | |
CA111399S (en) | Bottle | |
IL169935A0 (en) | Method, devices and reagents which are used for wastewater treatment | |
ZA200301077B (en) | Linked progressive jackpot system. | |
EG25273A (en) | Substituted dihydroquinazolines. | |
CA111400S (en) | Bottle | |
TW200510398A (en) | Novel compounds | |
MXPA05012562A (es) | Combinaciones antiartritis. | |
ZA200401520B (en) | Mineral oil activator. | |
WO2004105696A3 (en) | Combination therapy for the treatment of neoplasms | |
MXPA05012742A (es) | Composiciones de tratamiento para el cabello. | |
MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
WO2004050834A3 (en) | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER | |
TW200714284A (en) | Novel method | |
GB2420925B (en) | Radar apparatus or like | |
GB0323078D0 (en) | Sewage treatment | |
LU91022B1 (en) | Sektionaltor. | |
GB0325838D0 (en) | Wastewater treatment | |
ITVA20030011A1 (it) | Ingrassi per pelli e loro applicazione. | |
GB0322017D0 (en) | The treatment of arthritis | |
ES1053365Y (es) | Batea/vivero circular o eliptica para cria de pulpo. | |
ZA200308888B (en) | Sliding gate. | |
ZA200404236B (en) | Shears or the like. |